Efficacy and Outcome of Allogeneic Transplantation in IgD and Nonsecretory Myeloma. A Report on Behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Efficacy and Outcome of Allogeneic Transplantation in IgD and Nonsecretory Myeloma. A Report on Behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Published:2015-06 Issue:6 Volume:21 Page:1054-1058
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Morris Curly,Iacobelli Simona,Gahrton Gösta,van Biezen Anja,Drake Mary,Garderet Laurent,Potter Michael,Schattenberg Anton V.,Cornelissen Jan J.,Hamladji Rose-Marie,Martelli Massimo,Petersen Eefke,Rovira Montserrat,Bandini Giuseppe,Kroger Nicolaus,de Witte Theo

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference14 articles.

1. Efficacy and outcome of autologous transplantation in rare myelomas;Morris;Haematologica,2010

2. IgD multiple myeloma–a clinical profile and outcome with chemotherapy and autologous stem cell transplantation;Wechalekar;Ann Hematol,2005

3. The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes;Sharma;Am J Hematol,2010

4. Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR Study;Reece;Clin Lymphoma Myeloma Leuk,2010

5. High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future;Björkstrand;Semin Hematol,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials;Blood Advances;2022-09-01

2. A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing;Journal of Experimental & Clinical Cancer Research;2022-03-08

3. Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?;Journal of Genetic Engineering and Biotechnology;2020-07-28

4. Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study;Blood Advances;2019-03-04

5. Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series;Biology of Blood and Marrow Transplantation;2016-01